Microsynth (founded in 1989) is a European leading company in the area of DNA/RNA synthesis & analysis. The main activities are divided into following three business areas:

1. DNA/RNA SYNTHESIS
DNA/RNA oligos & probes for R&D
Antisense oligos (e.g. 2’-MOE or LNA-gapmers) for drug discovery
DNA oligos for diagnostic applications
Pilot scale synthesis (gram quantities)

2. DNA/RNA Analysis and Sequencing
Sanger sequencing (incl. GMP sequencing)
NGS sequencing (16S/ITS, RNA-Seq, etc.)
PCR & qPCR & digital PCR
Genotyping (GBS, cell lines, fragment analysis)
DNA/RNA isolation

3. Contract Research/Outsourcing
Assay development (e.g. IVD, liquid biopsy, etc.)
Assay validation (e.g. validation of assays according to ICH guidelines)
Biological tests (e.g. batch and release tests for drugs)
Gene editing/gene therapy (e.g. CRISPR editing analysis, rAAV characterization)

At its headquarter in Balgach close to St. Gallen Microsynth employs a staff of about 60 people. Microsynth has subsidiaries in Austria (Microsynth Austria GmbH) and Germany (Seqlab GmbH).